Skip to Content

1Life Healthcare, Inc. 

Merger

  • Date:
  • 6/11/2021
  • Company Name:
  • Iora Health, Inc.
  • Company Name - Buyer:
  • 1Life Healthcare, Inc.
  • Stock Symbol - Buyer:
  • ONEM
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 6/7/2021

Case Finder

Locate any case using the tools below.

NEW YORK, June 11, 2021 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of 1Life Healthcare, Inc. (NASDAQ: ONEM) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition of Iora Health, Inc.

On June 7, 2021, 1Life announced that it had signed an agreement to merge with Iora in an all-stock deal worth approximately $2.1 billion.  Pursuant to the merger agreement, Iora stockholders will receive 56.1 million shares of 1Life common stock.  The deal is scheduled to close in the second half of 2021.

Bragar Eagel & Squire is concerned that 1Life’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.  Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for 1Life’s stockholders.
 
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Iora Health. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: